Home / World News / US plans Covid-19 booster shots at six months instead of eight: Report

US plans Covid-19 booster shots at six months instead of eight: Report

Pfizer and BioNTech have already started the application process for the approval of its booster shot in people 16 and older

Premium

Approval of boosters for three Covid-19 shots being administered in the United States include those manufactured by Pfizer and partner BioNTech SE.

Reuters

1 min read Last Updated : Aug 27 2021 | 2:37 AM IST

US health regulators could approve a third Covid-19 shot for adults beginning at least six months after full vaccination, instead of the previously announced eight-month gap, the Wall Street Journal reported on Wednesday.

Approval of boosters for three Covid-19 shots being administered in the United States include those manufactured by Pfizer and partner BioNTech SE. Moderna and Johnson & Johnson are expected in mid-September, the report said, citing a person familiar with the plans.

Pfizer and BioNTech have already started the application process for the approval of its booster shot in people 16 and older, saying it spurs a more than

Disclaimer: No Business Standard Journalist was involved in creation of this content

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in